<h3>Gainers</h3>
<ul>
<li>Pomdoctor (NASDAQ:POM) shares rose 33.0% to $0.36 during Friday's pre-market session. The market value of their outstanding shares is at $32.2 million. </li>
<li>OnKure Therapeutics (NASDAQ:OKUR) shares increased by 19.17% to $5.47. The company's market cap stands at $62.7 million. </li>
<li>GlucoTrack (NASDAQ:GCTK) shares rose 17.42% to $1.28. </li>
<li>Lantern Pharma (NASDAQ:LTRN) stock moved upwards by 12.44% to $2.35. The market value of their outstanding shares is at $23.3 million. </li>
<li>Rocket Pharmaceuticals (NASDAQ:RCKT) shares increased by 11.3% to $5.22. The company's market cap stands at $509.1 million. </li>
<li>ADMA Biologics (NASDAQ:ADMA) shares increased by 10.73% to $9.18. The market value of their outstanding shares is at $1.9 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ENDRA Life Sciences (NASDAQ:NDRA) shares fell 12.4% to $4.02 during Friday's pre-market session. The company's market cap stands at $5.3 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:UPC) shares fell 10.26% to $2.1. The market value of their outstanding shares is at $1.3 million. </li>
<li>Acumen Pharmaceuticals (NASDAQ:ABOS) stock declined by 10.2% to $2.29. The market value of their outstanding shares is at $154.4 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Quoin Pharmaceuticals (NASDAQ:QNRX) shares decreased by 9.99% to $6.81. The market value of their outstanding shares is at $12.2 million. The company's, Q4 earnings came out yesterday. </li>
<li>Zenas BioPharma (NASDAQ:ZBIO) stock declined by 9.93% to $19.96. The company's market cap stands at $1.2 billion. </li>
<li>Impact BioMedical (AMEX:IBO) stock fell 9.3% to $0.51. The company's market cap stands at $60.8 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RCKT

In Friday's pre-market session, several health care stocks experienced notable movements. Pomdoctor (POM) shares surged 33% to $0.36, while OnKure Therapeutics (OKUR) rose 19.17% to $5.47. Other gainers included GlucoTrack (GCTK) up 17.42% to $1.28, Lantern Pharma (LTRN) up 12.44% to $2.35, and Rocket Pharmaceuticals (RCKT) up 11.3% to $5.22. Conversely, ENDRA Life Sciences (NDRA) fell 12.4% to $4.02, Universe Pharmaceuticals (UPC) dropped 10.26% to $2.1, and Acumen Pharmaceuticals (ABOS) declined 10.2% to $2.29. Quoin Pharmaceuticals (QNRX) and Zenas BioPharma (ZBIO) also saw declines following their Q4 earnings reports.

benzinga_article

iShares US Pharma

SPDR S&P Biotech

Rocket Pharma

VanEck Biotech ETF

Endra Life Sciences

iShares US Medical Devices

Quoin Pharmaceuticals

Pomdoctor

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

VG Health

iShares Global Healthcare

Invesco Nasdaq Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Lantern Pharma

ALPS Medical Breakthrough

Acumen Pharmaceuticals

OnKure Therapeutics

Health Care Select Sector SPDR

Universe Pharmaceuticals

SPDR S&P Health Equip

12 Health Care Stocks Moving In Friday's Pre-Market Session